Skip to content

Big differences in virological outcomes among people taking first-line HIV therapy in resource-limited settings

HIV-positive people not on antiretrovirals are prone to inflammation-related bone loss

Corrilynn Hileman, from Case Western Reserve University, speaking at the ID Week Conference.

Eviplera works well regardless of viral load or CD4 count, may improve lipid levels

Pablo Tebas, University of Pennsyvania, reports results of the SPIRIT study at ID Week 2013. Photo by Liz Highleyman, hivandhepatitis.com

People with HIV have higher risk of death after heart attack

Michael Silverberg, of Kaiser Permanente, speaking at the ID Week Conference.

Does efavirenz use raise the risk of suicide in people with HIV?

Katie Mollan,  from the University of North Carolina, speaking at the ID Week Conference.

Studies look at community vs hospital-based HIV care and medication issues

Elizabeth Neuner from the Cleveland Clinic and HIV Medicine Association chair Michael Horberg, at the ID Week Conference.

Liver fibrosis linked to immune activation in HIV/HCV co-infected women

Andrea Kovacs, from the Keck School of Medicine in Los Angeles, speaking at the ID Week Conference.

Long-acting antiretrovirals may improve survival for people with poor adherence

Eric Ross, from Massachusetts General Hospital in Boston, speaking at the ID Week Conference.

Liver cancer often diagnosed late with poor survival in people with HIV

Juan Berenguer, from Hospital Gregorio Marañón, speaking at ICAAC 2013.